707 SP 7.5 (Univasc 7.5 mg)

Generic Name: moexipril

Pill imprint 707 SP 7.5 has been identified as Univasc 7.5 mg.

Univasc is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Univasc 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Univasc

Generic Name:

moexipril

Imprint:

707 SP 7.5

Strength:

7.5 mg

Color:

Pink

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Schwarz Pharma

National Drug Code (NDC):

00091-3707

Inactive Ingredients:

lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose (type h)
hypromelloses
polyethylene glycol 6000
titanium dioxide
ferric oxide red

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.